Oncology

Filter

Chlormethine Gel Reshapes the Tumour Microenvironment in Mycosis Fungoides

9 Mins

March 2026

Cutaneous T cell lymphomas (CTCL) are a heterogenous group of rare malignancies primarily involving the skin, of which mycosis fungoides…

Chlormethine Gel Reshapes the Tumour Microenvironment in Mycosis Fungoides

Cutaneous T cell lymphomas (CTCL) are a heterogenous group of rare malignancies primarily involving the skin, of which mycosis fungoides…

26 Mar 2026

New Horizons in Anal Cancer and CRC

Latest advances in the management of squamous cell anal cancer across both early-stage and advanced disease, highlighting the growing role…

Dual Hypersensitivity in Ovarian Cancer

Carboplatin and paclitaxel remain the cornerstone of first-line chemotherapy for advanced ovarian cancer, as recommended by…

PI3Kα Inhibitor for Breast Cancer

Zovegalisib (RLY-2608) is the first pan-mutant-selective PI3Kα inhibitor, binding a novel allosteric site distinct from approved…

Recent Developments in NMIBC Research

Globally, there are more than 650,000 newly diagnosed cases of bladder cancer annually, with up to approximately 80% of these cases…

2L+ ER+/HER2- Metastatic Breast Cancer

This symposium took place during the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany. The aim of the…

Unwrapped 2025

Unwrap the Best of Oncology

It’s time for Unwrapped 2025. Explore Oncology’s defining moments, our Word of the Year, and a challenging brain teaser.

Evidence-Based Treatment of mCRPC

This satellite symposium at the European Society for Medical Oncology (ESMO) Congress 2025, chaired by Rana McKay, Professor of…

Loading posts...

1 2 3 … 31 Next »